SCT BIO
Live / Registered — Registered (as of 12 Dec 2023)
What this means for you
Registered since 12 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79345925
- Registration number
- 7238443
- Mark type
- Word mark
- Filed
- 14 Apr 2022
- Published for opposition
- 26 Sept 2023
- Registered
- 12 Dec 2023
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 039 — Transportation and storage services: Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
- Class 040 — Treatment of materials: Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
- Class 042 — Scientific and technological services: Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies
Owner
Prosecution history
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Apr 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Mar 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Mar 2024 — FINAL DISPOSITION PROCESSED
- 12 Mar 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 26 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Sept 2023 — PUBLISHED FOR OPPOSITION
- 25 Sept 2023 — NOTIFICATION PROCESSED BY IB